{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:57:06Z","timestamp":1792065426277,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011851","name":"Kom op tegen kanker","doi-asserted-by":"publisher","award":["0010048"],"award-info":[{"award-number":["0010048"]}],"id":[{"id":"10.13039\/501100011851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.adro.2026.102072","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:13:17Z","timestamp":1780013597000},"page":"102072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hematological Toxicity and Bone Marrow Dose-Volume Effects in Chemotherapy-Na\u00efve Patients Treated With Whole Pelvic and Para-aortic Lymph Node Radiation Therapy For Pathologic Pelvic Lymph Node\u2013Positive Prostate Cancer"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2830-2453","authenticated-orcid":false,"given":"Julie","family":"den Hartog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"De Meerleer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annouschka","family":"Laenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"De Roover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Slabbaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herlinde","family":"Dumez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Giesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kato","family":"Rans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102072_bib0001","unstructured":"Belgian Cancer Registry (BCR). Cancer Fact Sheets 2022.2024. Accessed September 3, 2025. https:\/\/kankerregister.org\/sites\/default\/files\/2024\/20241213_BE_CFS_PROSTATE_V1.pdf"},{"key":"10.1016\/j.adro.2026.102072_bib0002","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.2025.0228","article-title":"Prostate cancer: A review","volume":"333","author":"Raychaudhuri","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2026.102072_bib0003","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euros.2025.07.008","article-title":"Prognostic stratification of pN1 prostate cancer after radical prostatectomy: A competing risk analysis from a multi-institutional cohort","volume":"79","author":"Giesen","year":"2025","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.adro.2026.102072_bib0004","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/cncr.30373","article-title":"The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer","volume":"123","author":"Jegadeesh","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2026.102072_bib0005","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bju.14241","article-title":"Adjuvant radiation with androgen-deprivation therapy for men with lymph node metastases after radical prostatectomy: Identifying men who benefit","volume":"123","author":"Gupta","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2026.102072_bib0006","doi-asserted-by":"crossref","first-page":"djv119","DOI":"10.1093\/jnci\/djv119","article-title":"Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer","volume":"107","author":"Lin","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2026.102072_bib0007","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2013.54.7893","article-title":"Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer","volume":"32","author":"Abdollah","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102072_bib0008","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pros.21420","article-title":"Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum","volume":"72","author":"Briganti","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.adro.2026.102072_bib0009","doi-asserted-by":"crossref","DOI":"10.2196\/11256","article-title":"Benefits of elective para-aortic radiotherapy for pN1 prostate cancer using arc therapy (intensity-modulated or volumetric modulated arc therapy): Protocol for a nonrandomized phase II trial","volume":"7","author":"Draulans","year":"2018","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.adro.2026.102072_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.796907","article-title":"Efficacy and toxicity of whole pelvic radiotherapy versus prostate-only radiotherapy in localized prostate cancer: A systematic review and meta-analysis","volume":"11","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2026.102072_bib0011","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2967\/jnumed.107.044354","article-title":"Method for estimating skeletal spongiosa volume and active marrow mass in the adult male and adult female","volume":"48","author":"Pichardo","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2026.102072_bib0012","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1158\/1078-0432.CCR-23-3632","article-title":"Translational frontiers and clinical opportunities of immunologically fitted radiotherapy","volume":"30","author":"Morel","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.adro.2026.102072_bib0013","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2307\/3572441","article-title":"Extracorporeal irradiation of blood in man: Radiation resistance of circulating platelets","volume":"35","author":"Greenberg","year":"1968","journal-title":"Radiat Res."},{"key":"10.1016\/j.adro.2026.102072_bib0014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/07357907.2022.2139838","article-title":"Impact of radiation therapy on biological parameters in cancer patients: Sub-analysis from the RIT prospective epidemiological study","volume":"41","author":"Magn\u00e9","year":"2023","journal-title":"Cancer Invest"},{"key":"10.1016\/j.adro.2026.102072_bib0015","doi-asserted-by":"crossref","first-page":"15519","DOI":"10.1039\/D1RA01948A","article-title":"Quantifying the influences of radiation therapy on deformability of human red blood cells by dual-beam optical tweezers","volume":"11","author":"Inanc","year":"2021","journal-title":"RSC Adv"},{"key":"10.1016\/j.adro.2026.102072_bib0016","first-page":"437","article-title":"Radiation therapy-associated toxicity: Etiology, management, and prevention","volume":"71","author":"Wang","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2026.102072_bib0017","series-title":"Basic Clinical Radiobiology Fourth Edition","first-page":"169","article-title":"Pathogenesis of normal-tissue side-effects","author":"D\u00f6rr","year":"2009"},{"key":"10.1016\/j.adro.2026.102072_bib0018","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ijrobp.2009.11.062","article-title":"Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data","volume":"78","author":"Liang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102072_bib0019","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0360-3016(94)00430-S","article-title":"Hematopoietic stem cell compartment: Acute and late effects of radiation therapy and chemotherapy","volume":"31","author":"Mauch","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102072_bib0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13287-024-03853-7","article-title":"Insights into ionizing radiation-induced bone marrow hematopoietic stem cell injury","volume":"15","author":"Zhang","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.adro.2026.102072_bib0021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semradonc.2008.11.006","article-title":"Bone marrow-derived stem cells and radiation response","volume":"19","author":"Greenberger","year":"2009","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102072_bib0022","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3390\/cancers16101842","article-title":"Hematologic toxicity and bone marrow-sparing strategies in chemoradiation for locally advanced cervical cancer: A systematic review","volume":"16","author":"Konnerth","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2026.102072_bib0023","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ijrobp.2022.05.040","article-title":"Para-aortic radiation therapy for oligorecurrent prostate cancer","volume":"114","author":"Rich","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102072_bib0024","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.3390\/jcm13113291","article-title":"SBRT in lymph-nodal oligometastases from prostate cancer: Different outcomes between pelvic and para-aortic disease","volume":"13","author":"Pastorello","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.adro.2026.102072_bib0025","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.03 2010. Accessed September 3, 2025. https:\/\/www.eortc.be\/services\/doc\/ctc\/ctcae_4.03_2010-06-14_quickreference_5x7.pdfhttp:\/\/www.meddramsso.com"},{"key":"10.1016\/j.adro.2026.102072_bib0026","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2007.08.074","article-title":"Association between bone marrow dosimetric parameters and acute hematologic toxicity in anal cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy","volume":"70","author":"Mell","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102072_bib0027","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Stat Methodol."},{"key":"10.1016\/j.adro.2026.102072_bib0028","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0301-472X(02)00802-0","article-title":"Hematologic consequences of exposure to ionizing radiation","volume":"30","author":"Dainiak","year":"2002","journal-title":"Exp Hematol."},{"key":"10.1016\/j.adro.2026.102072_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1459732","article-title":"Late radiation-related lymphopenia after prostate stereotactic body radiation therapy plus or minus supplemental pelvic irradiation","volume":"14","author":"Gaudian","year":"2024","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2026.102072_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrrev.2021.108365","article-title":"Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer","volume":"787","author":"Caliri","year":"2021","journal-title":"Mutat Res Rev Mutat Res"},{"key":"10.1016\/j.adro.2026.102072_bib0032","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/bju.12969","article-title":"Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity","volume":"116","author":"Steinberger","year":"2015","journal-title":"BJU Int"},{"key":"10.1016\/j.adro.2026.102072_bib0034","doi-asserted-by":"crossref","first-page":"847","DOI":"10.15537\/smj.2015.7.11026","article-title":"Effects of cigarette smoking on morphological features of platelets in healthy men","volume":"36","author":"Ghahremanfard","year":"2015","journal-title":"Saudi Med J"},{"key":"10.1016\/j.adro.2026.102072_bib0035","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1016\/j.jtha.2023.06.012","article-title":"Glucocorticoids regulate thrombopoiesis by remodeling the megakaryocyte transcriptome","volume":"21","author":"Grodzielski","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.adro.2026.102072_bib0036","doi-asserted-by":"crossref","first-page":"E1185","DOI":"10.1152\/ajpendo.00272.2018","article-title":"Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer","volume":"315","author":"Gagliano-Juc\u00e1","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.adro.2026.102072_bib0037","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03345745","article-title":"Androgens and erythropoiesis: Past and present","volume":"32","author":"Shahani","year":"2009","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.adro.2026.102072_bib0038","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1097\/EDE.0000000000000678","article-title":"Androgen deprivation therapy and the risk of anemia in men with prostate cancer","volume":"28","author":"Hicks","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.adro.2026.102072_bib0039","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2022.03.031","article-title":"Intensification of systemic therapy in addition to definitive local treatment in nonmetastatic unfavourable prostate cancer: A systematic review and meta-analysis","volume":"82","author":"Rajwa","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.adro.2026.102072_bib0040","article-title":"Risk of fatigue and anemia in patients with prostate cancer treated with novel oral anti-androgens: A meta-analysis of randomized controlled trials","volume":"14","author":"Babkoor","year":"2022","journal-title":"Cureus."},{"key":"10.1016\/j.adro.2026.102072_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110230","article-title":"Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer","volume":"195","author":"Pavarini","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102072_bib0042","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ijrobp.2016.01.022","article-title":"Hematologic toxicity in patients treated with postprostatectomy whole-pelvis irradiation with different intensity modulated radiation therapy techniques is not negligible and is prolonged: preliminary results of a longitudinal, observational study","volume":"95","author":"Cozzarini","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102072_bib0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1448658","article-title":"Editorial: Updates on radiation-induced lymphopenia","volume":"14","author":"Damen","year":"2024","journal-title":"Front Oncol."},{"key":"10.1016\/j.adro.2026.102072_bib0043","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: A systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102072_bib0044","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.7150\/ijms.95900","article-title":"Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients","volume":"21","author":"Deng","year":"2024","journal-title":"Int J Med Sci"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109426000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:35:52Z","timestamp":1792064152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109426000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2452109426000795"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102072","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematological Toxicity and Bone Marrow Dose-Volume Effects in Chemotherapy-Na\u00efve Patients Treated With Whole Pelvic and Para-aortic Lymph Node Radiation Therapy For Pathologic Pelvic Lymph Node\u2013Positive Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102072"}}